Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
6.96
+0.06 (0.87%)
Dec 20, 2024, 4:00 PM EST - Market closed

Treace Medical Concepts Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
4347861,276991--
Market Cap Growth
-55.29%-38.37%28.74%---
Enterprise Value
4217351,259911--
Last Close Price
6.9612.7522.9918.64--
PS Ratio
2.134.209.0010.50--
PB Ratio
4.135.7021.0810.65--
P/TBV Ratio
4.316.7721.0810.65--
EV/Sales Ratio
2.073.938.889.65--
Debt / Equity Ratio
0.670.511.130.3240.236.08
Debt / EBITDA Ratio
----15.12-
Asset Turnover
0.900.910.951.031.60-
Inventory Turnover
1.081.451.711.841.86-
Quick Ratio
2.813.613.676.832.813.08
Current Ratio
4.124.404.417.583.533.90
Return on Equity (ROE)
-50.69%-49.91%-55.75%-43.80%-186.33%-
Return on Assets (ROA)
-17.13%-15.59%-14.53%-11.30%1.49%-
Return on Capital (ROIC)
-20.25%-18.99%-17.30%-13.35%1.97%-
Earnings Yield
-14.19%-6.30%-3.36%-2.07%--
FCF Yield
-9.96%-5.85%-3.56%-2.01%--
Buyback Yield / Dilution
-4.46%-10.09%-14.17%-30.61%-0.43%-
Total Shareholder Return
-4.46%-10.09%-14.17%-30.61%-0.43%-
Source: S&P Capital IQ. Standard template. Financial Sources.